The NOVOS range — Bar, Vital, Core, Boost — on a terrace table

Your Partner in Longevity.

Join our growing network of healthcare professionals helping patients live younger for longer.

Shared by 2,000+ clinicians on FrontrowMD.

Why Healthcare Professionals Choose NOVOS

Harvard and MIT Scientists

Clinically Studied

Patient Education

Competitive Tier-Based Wholesale Pricing

NOVOS Core box with a daily sachet

NOVOS Core

Developed over 8+ years of R&D, with ingredients selected using research on the 12 Hallmarks of Aging. Its finished formula was studied in a randomized, double-blind, placebo-controlled human trial in healthy men and women aged 40+, which showed benefits to cardiovascular aging markers. See the clinical study

  • Cardiovascular Aging Support
  • Cellular Energy & Recovery
  • Skin Structure & Renewal
  • Brain Function & Emotional Balance
8

Years of research

We follow the science, from mechanism to preclinical validation to human-relevant outcomes, refining our formulas as the evidence evolves.

950+

Studies Reviewed

Our formulations are built on ingredients backed by more than 950 peer-reviewed longevity and aging publications.

7

Scientists and Physicians

Developed in collaboration with leading longevity scientists and physicians from Harvard Medical School, MIT, the Salk Institute, and beyond.

3

Formulation Studies

Including a randomized, double-blind, placebo-controlled human trial published in European Heart Journal Open, a mouse lifespan study, and in vitro research published in Nutrients.

Explore the research

Individual results may vary. Peer-reviewed and published in European Heart Journal Open (2026).

+2.9%

Endothelial Function (FMD)

−1.18 m/s

Arterial Flexibility (PWV)

−6.1 mmHg

Beneficial effect on blood pressure

(for blood pressures already in normal range)

For Healthcare Providers.

Create a NOVOS provider account or apply to get exclusive access to products, pricing, and education.

NOVOS Boost bottle standing in rippling water

Created with the Greatest Minds in Longevity

Portrait illustration of Dr. George Church, PhD

Dr. George Church, PhD

Harvard Medical School & MIT Professor

Portrait illustration of Dr. Pamela Maher, PhD

Dr. Pamela Maher, PhD

University of British Columbia, Salk Institute for Biological Studies

Portrait illustration of Dr. Oliver Medvedik, PhD

Dr. Oliver Medvedik, PhD

Harvard Medical School, The Cooper Union

Portrait illustration of Dr. J Pedro de Magalhaes, PhD

Dr. J Pedro de Magalhaes, PhD

Harvard Medical School, University of Birmingham

Portrait illustration of Dr. Avi Rosenbaum, PhD

Dr. Avi Rosenbaum, PhD

Harvard Medical School

Portrait illustration of Dr. Robert Lufkin, MD

Dr. Robert Lufkin, MD

USC School of Medicine

For Wholesale Partners

Interested in Distributing NOVOS Products in Store, Online, or at Your Practice?

Exclusive wholesale pricing, staff training, and marketing support for your practice.

Apply Now

On the NOVOS Core Clinical Trial

“Taken together, improvements across endothelial function, arterial stiffness (PWV), and systolic blood pressure point to a coherent pattern consistent with a favorable shift in vascular aging biology…”
Prof. Christian HeissLead author of the NOVOS Core RCT (via Medical News Today)
“In particular, the magnitude of improvement in flow-mediated dilation stood out, because it is a well-established functional marker of endothelial health… That kind of consistency is not common in supplement trials, especially in adults without established cardiovascular disease.”
Dr. Yivia Medical News Today

Third-party commentary on the NOVOS Core randomized controlled trial. Peer-reviewed and published in European Heart Journal Open (2026).

Upgrade Your Longevity Routine

Daily Foundation
NOVOS Core
Start here

NOVOS Core

12 Hallmarks One daily drink Human clinical trial

Daily support for energy, sleep, focus, and whole-body resilience, with ingredients selected using research on the Hallmarks of Aging.

From $2.60/day.
Cellular Energy
NOVOS Boost

NOVOS Boost

99% pure NMN NAD+ support Pairs with Core

Targeted support for cellular energy, healthy metabolism, and staying strong as you age.

From $1.05/day.
Whole-Body Support
NOVOS Vital

NOVOS Vital

7 organ systems Daily gummies

Daily support for seven key organ systems, with ingredients chosen for cardiovascular and whole-body health.

From $1.63/day.
Longevity Nutrition
NOVOS Bar

NOVOS Bar

15g protein 7g fiber Up to 20 superfoods

Protein, fiber, superfoods, and key longevity nutrients for the days a full meal is hard to get to.

$3.60 per bar with subscription.

Frequently Asked Questions

Who qualifies for a NOVOS provider account?

Licensed physicians, clinics, and allied practitioners, plus retail and hospitality partners carrying NOVOS on site. Every application is reviewed by the partnerships team before the account opens.

How does tier-based wholesale pricing work?

Wholesale pricing is tiered by order volume: the more you order, the deeper the discount. Every provider starts at our entry tier and can move up as volume grows. Your account manager can confirm which tier applies to you and what it would take to reach the next one.

What clinical evidence supports NOVOS Core?

The NOVOS Core finished formula was studied in a randomized, double-blind, placebo-controlled human trial that randomized 61 healthy men and women aged 40+. Our provider resource library includes study summaries and the full reference list.

What patient education materials come with the account?

Regimen guides, ingredient one-pagers, and the 12 Hallmarks of Aging explainer, plus staff training from NOVOS longevity specialists and event support.

Can patients reorder on their own?

Yes. Patients can order directly through their own NOVOS account, and practices can dispense from inventory held on site.

Is there a minimum order?

No. Our entry tier has no minimum order requirement, so you can start with as much or as little product as makes sense for your practice. As your order volume grows, additional pricing tiers offer higher margins based on quantity.

Randomized human trial · Cardiovascular

NOVOS Core Improved Three Markers of Cardiovascular Aging

Versus placebo in generally healthy men and women aged 40+, with measurements taken at baseline, one hour, and six months.

  • Randomized
  • Placebo-controlled
  • Double-blind
  • Peer-reviewed
Blood Vessel Function +2.9pp Flow-Mediated Dilation (FMD) Measures how well blood vessels widen in response to increased blood flow. NOVOS Core improved FMD in just one hour and by 2.9 percentage points versus placebo at six months. A 1% improvement is considered clinically meaningful.
Vascular Flexibility −1.18 m/s Pulse Wave Velocity (PWV) Measures how quickly pressure waves travel through the arteries. Slower speeds indicate more flexible arteries. NOVOS Core improved PWV by 1.18 m/s versus placebo at six months.
Blood Pressure −6.1 mmHg Systolic Blood Pressure (SBP) Measures the pressure in the arteries when the heart contracts. NOVOS Core reduced systolic blood pressure by 6.1 mmHg versus placebo at six months in participants whose blood pressure was already within the normal range.

Endothelial function over the trial

FMD measured at baseline, 1 hour, and 6 months. Significant vs placebo at both.

FMD response (illustrative shape)Baseline1 hour6 months∗∗+2.9pp vs placebo
NOVOS Core Placebo

∗ p < 0.001 vs placebo. The 1-hour and 6-month points are study measurement timepoints, not a promised timeline of individual results.

Systolic Blood Pressure: NOVOS Core vs. Placebo

Change from baseline at six months. Both groups stayed within the normal range.

NOVOS Core −8.5 mmHg
Placebo −1.5 mmHg

Placebo-adjusted difference: −6.1 mmHg (for blood pressures already in normal range).

These benefits were observed in healthy adults already within normal ranges, where further change is typically harder to achieve.
Study details
Single-center, double-blind, randomized, placebo-controlled trial in generally healthy men and women aged 40+. Participants took one serving of NOVOS Core daily for six months. Senior author: Prof. Christian Heiss, Professor of Cardiovascular Medicine, University of Surrey. Published in European Heart Journal Open (Oxford University Press), 2026.

“Taken together, improvements across endothelial function, arterial flexibility, and systolic blood pressure point to a coherent pattern consistent with a favorable shift in vascular aging biology.”

Professor Christian Heiss, MD · University of Surrey · Professor of Cardiovascular Medicine, Associate Head of Medical School Senior Author of the NOVOS Core study

*This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Individual responses vary. Not every person will experience the same magnitude of change. This study did not assess clinical disease outcomes. Individual results may vary.

NOVOS Insider

We’ve got you covered

Go beyond the longevity solutions and get an insider view of the latest breakthrough science. NOVOS is a Public Benefit Corporation that provides science-based tips, actionable guidance, and expert-backed tools to the public for free.

Join our NOVOS community today to be Younger For Longer!

Free gifts unlocked!

Choose your merch gifts

Your Cart 0

Your cart is empty

Start your longevity protocol with NOVOS.

Shop NOVOS
Subtotal

Shipping, taxes & subscription details are calculated at checkout.